Objective-To describe the relation between the extent of a myocardial infarct, measured according to maximum serum enzyme activity of lactate dehydrogenase, and mortality at 10 years. Patients-In 759 patients with acute myocardial infarction in whom serum activity of heat stable lactate dehydrogenase had been determined every 12 hours for 108 hours after randomisation in an early intervention trial with metoprolol. Main outcome measure-Mortality at 10 years in relation to quartile of maximum serum lactate dehydrogenase activity and history of cardiovascular disease.
51% in the second quartile, 50% in the third, and 590/o in the fourth (p < 0-001 for relation between infarct size and 10 year mortality). Among patients without a history of myocardial infarction, angina pectoris, diabetes mellitus, or hypertension the mortality in each quartile was 29%, 32%, 41%, and 56%, respectively (p < 0-001 for relation between infarct size and 10 year mortality). Among patients with any of these risk indicators the association between the estimated infarct size and mortality at 10 years was weak (p < 0.05).
Conclusion-Estimated size of a myocardial infarct and mortality over 10 years seem to be related but The inclusion criteria for participation in the trial were chest pain lasting at least 30 minutes or electrocardiographic changes indicating acute myocardial infarction with onset of symptoms within the previous 48 hours, or both, and age from 40 to 74 years. The cardiovascular exclusion criteria were a heart rate less than 45 beats/minute; systolic blood pressure less than 100 mm Hg; a PR interval greater than 0-24; and severe congestive heart failure defined as basal pulmonary rales greater than 10 cm. Further exclusion criteria have been presented elsewhere.8 Patients were given 15 mg metoprolol or placebo intravenously soon after admission to hospital and then 200 mg orally everyday for three months in a double blind fashion. Thereafter most patients with suspected ischaemic heart disease were given ,B blockade regardless of their original treatment group.
PROTOCOL
The criteria for definite infarction were fulfilment of at least two of the three following conditions: (a) chest pain lasting at least 15 minutes; (b) at least two blood samples with raised serum activity of aspartate aminotransferase (> 07 ,ukat/l) and decreased or normal activity of alanine aminotransferase; and (c) development of Q waves and appearance or disappearance of ST segment elevation followed by T wave inversion in at least two of the 12 leads in a standard electrocardiogram. An Overall, 1395 patients were included in the trial, of whom 809 (58%) fulfilled the criteria for acute myocardial infarction during their first three days in hospital. Information on serum lactate dehydrogenase activity and mortality over 10 years was available in 759 of these patients (94%). Table 1 shows the baseline characteristics of these patients. Half were randomly allocated to metoprolol and half to placebo treatment. Figure 1 shows mortality over 10 years for the four quartiles of lactate dehydrogenase activity when all patients were included in the analyses. Infarct size was significantly related to the overall 10 year mortality, including mortality during the initial stay in hospital, being 39% in the lowest quartile, 51% in the second quartile, 50% in the third, and 59% in the fourth (p < 0-001). When patients who were discharged alive from hospital were analysed separately the relation was weaker (p = 0 048). Mortality over 10 years was similar in those treated with metoprolol and placebo. After the first year the survival curves were parallel. MORTALITY Predictors were a history of diabetes mellitus, increasing age, presence of congestive heart failure during the stay in hospital, and a history of myocardial infarction.
MORTALITY IN RELATION TO INFARCT SIZE

Discussion
The main aim in treating patients with acute myocardial infarction is to try to contain the infarct as much as possible. Yet, knowledge about the association between the final extent of the infarct and the very long term prognosis is still insufficient. This study describes the relation between the estimated extent of a myocardial infarct and the overall mortality during 10 years of follow up. We have previously described the relation between estimated infarct size and mortality after three months," two years,4 and five years5 in the same population of patients.
We found an association between serum lactate dehydrogenase activity and mortality over 10 years in the univariate analysis. Thus 39% of patients with the smallest infarcts were dead after 10 years compared with 59% of patients with the largest infarcts. In the multivariate analysis, however, infarct size did not emerge as an independent predictor of death. Such predictors were instead a history of cardiovascular disease (particularly diabetes mellitus), previous acute myocardial infarction, and age. Therefore the association between infarct size and mortality was stronger when patients without a history of cardiovascular disease were analysed separately.
When the association between infarct size and mortality over five years was analysed the curves diverged during the first year after acute myocardial infarction, but not thereafter.5 In this study the mortality curves in the four quartiles were also parallel between five and 10 years after infarction. Thus the relation between infarct size and mortality over 10 years may reflect the much higher mortality among patients with larger infarcts during the first year after infarction.
The use of enzyme activity to determine infarct size has been criticised for being inaccurate'2 13 
